Skip to main content

Life Sciences

Why Monitoring Adverse Events And Drug Safety Signals Matters

It takes an average of 10 to 15 years and $2.6 billion for a drug to reach pharmacy shelves. While there are many steps in the process that contribute to this lengthy timeline and cost, no aspect of the process is more critical than proving the safety of a drug.

Since a patient’s health is at risk throughout the testing of a drug, as well as the life of a drug once it has been approved, companies must leverage the most advanced methodologies and industry tools to mitigate any risk to the public.

In an upcoming series of posts, I’ll discuss the importance of monitoring adverse events and safety signals to ensure patients are always kept safe, from research through post-approval. In the meantime, check out our latest guide on drug safety.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Indy Ahluwalia

More from this Author

Follow Us